Incyte and CMS Announce Collaboration and License Agreement for Ruxolitinib Cream in Greater China and Southeast Asia
WILMINGTON, Del. & HONG KONG--(BUSINESS WIRE)--$INCY--Incyte (NASDAQ:INCY) and CMS Aesthetics, a dermatology medical aesthetic company…